These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2198142)

  • 21. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of propafenone in anti-arrhythmia treatment].
    Furlanello F; Bertoldi A
    G Ital Cardiol; 1993 Oct; 23(10):1017-28. PubMed ID: 8174857
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 25. Sustained ventricular tachycardia occurring during propafenone therapy.
    De Jaegere P; Huyghens L; Dewilde P
    Acta Cardiol; 1987; 42(3):207-12. PubMed ID: 3499736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiarrhythmic effect of propafenone in relation to serum concentration and conduction time (author's transl)].
    Meyer-Estorf G; Keller K; Beck OA; Hochrein H
    Z Kardiol; 1978 May; 67(5):353-6. PubMed ID: 654420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propafenone--a new antiarrhythmic drug.
    Seipel L; Breithardt G
    Eur Heart J; 1980 Aug; 1(4):309-13. PubMed ID: 7023945
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: a case report.
    Barranco-Garduño L; Flores-Pérez J; Juárez-Olguín H; Bobadilla-Chávez J; Osnaya H; Flores-Pérez C
    Arch Cardiol Mex; 2009; 79(2):132-4. PubMed ID: 19722384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent convulsions and cardiac conduction disturbances after propafenone overdose.
    Rambourg-Schepens MO; Grossenbacher F; Buffet M; Lamiable D
    Vet Hum Toxicol; 1999 Jun; 41(3):153-4. PubMed ID: 10349704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 33. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG; Camm AJ
    Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current understanding of lidocaine as an antiarrhythmic agent: a review.
    Anderson JL
    Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raised serum levels of desipramine with the antiarrhythmic propafenone.
    Katz MR
    J Clin Psychiatry; 1991 Oct; 52(10):432-3. PubMed ID: 1938981
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propafenone (rythmol) for ventricular arrhythmias.
    Porterfield LM
    Adv Clin Care; 1990; 5(5):41. PubMed ID: 2393507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.